News

AI-Powered Contouring in Radiotherapy: The MVision Contour+ Impact
MVision Contour+ is an AI-powered auto-segmentation used in radiation therapy planning. Recently, a series of studies published in peer-reviewed journals evaluated its performance and impact…
The Promise of AI in Radiation Oncology: A Discussion with Professor Pierre Thirion
Radiation Oncology is a medical specialty that, at its core, combines technology and medicine, creating opportunities for spectacular improvements and advances in a relatively short…
MVision AI Announces Dose+: Dose Prediction Software for AI-driven Radiation Therapy Planning
Helsinki, Finland – February 2025 – MVision AI announces the introduction of Dose+, a software medical device designed to assist radiation therapy professionals in treatment…
MVision AI’s Contour+ MR Models Achieve TGA Market Approval in Australia
Helsinki, Finland – February 2025 – The Therapeutic Goods Administration (TGA) of Australia has granted market approval for MVision AI’s MR-based segmentation models included in…
Lung Cancer Awareness–Examining Tobacco’s Effect
As August comes to a close, we take a moment to reflect on World Lung Cancer Day, observed earlier this month. This year’s focus has…
World Kidney Cancer Day 2024: “Listen”
World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of…
World Cancer Day – Joining efforts for a better cancer care
World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International…
🎉 Exciting News: AI Auto-Contouring Recommended by NICE for Radiotherapy in the NHS! 🎉
We are thrilled to share a significant milestone that showcases the remarkable impact of innovation in radiotherapy. A number of AI auto-contouring tools, including MVision…
MVision: 2022 year in review
2022 came to an end. Seeing our names of customers, the number of scans and countries marked on the map, we know, we reached our…
MVision’s GBS™ is Featured in 5 Posters at the German Society of Radiation Oncology (DEGRO) Annual Meeting
This week, we’re focusing on high-impact research presented during the German Society of Radiation Oncology (DEGRO) Annual Meeting. Five posters included a focus on MVision’s…